Liu et al. investigated 99 cases with MDS or MDS that progressed to AML and observed that ASXL1 mutations occurred more frequently with ETV6, RUNX1, and SRSF2 mutations [35]. This evidence concerns the gene RUNX1 and acute myeloid leukemia.